P117 real-world perspectives of health care providers delivering the first approved treatment for peanut allergy

In January 2020, Peanut (Arachis hypogaea) Allergen Powder-dnfp (PTAH) became the first treatment for Peanut Allergy (PA) approved by the US Food and Drug Administration (FDA). The adoption of innovative new therapies requires consideration of the skills, logistics and practicalities required for implementation.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2021 Category: Allergy & Immunology Authors: A. Anagnostou, C. Lawrence, P. Swinburn, S. Tilles, S. Laubach, S. Acaster, S. Donelson, M. Yassine, A. Nowak-Wegrzyn Source Type: research